Skip to main content
Premium Trial:

Request an Annual Quote

Waters Shares Spike 14 Percent on Strong Q4 Earnings

NEW YORK, Jan.24 (GenomeWeb News) - Waters shares rallied as much as 14 percent in Tuesday trade after the company reported a growth of 7 percent in fourth-quarter organic sales.


The stock was trading up $5.24 or 13.88 percent, at $43 in afternoon trade.


As GenomeWeb News reported earlier this morning, Waters posted fourth-quarter sales growth of 3 percent on strong growth in its chromatography business and sales in Asia.


Total sales for the three months ended Dec. 31 increased to $332 million from $324 million one year ago. Eliminating the effects of foreign currency, sales grew by 7 percent, the company said.


R&D spending in the period increased slightly to $16.7 million from $16.5 million year over year.


Waters' net income increased to $78.2 million, or $0.72 per basic share, from $71.5 million, or $0.59 per basic share in the year-ago period.


CEO and President Douglas Berthiaume said the revenue and profit "exceeded our expectations."


As of Jan. 1, Waters had approximately $494 million in cash and equivalents on hand.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.